Amphion Innovations (AMP)

 

AMP Share PerformanceMore

52 week high5.2000 08/08/16
52 week low2.1750 30/11/16
52 week change -1.8750 (-44.12%)
4 week volume3,672,462 11/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

Notification of major interests in shares

Amphion re-negotiates terms of Motif CPN

Amphion, a developer of medical, life science, and technology businesses, has re-negotiated the terms of the convertible pro...

Re-negotiated terms of Motif CPN

Miscellaneous medium priority announcements

Amphion NAV up

Amphion Innovations' net asset value per ordinary share rose to 4.3p in the six months to the end of June from 3.8p at year...

Interim Results for the six months to 30 June 2016

RNS Number: 1359J Amphion Innovations PLC 07 September 2016 Amphion Innovations plc Interim Results for the six months to 30 June 2016 London and New York, 7 September 2016 - Amphion Innovations plc (LSE: AMP) ( " Amphion " or the " Company"), the developer of medical and technology businesses, today announces its unaudited interim results for the...

Additional Draw Down on Loan Facility

RNS Number: 8230H Amphion Innovations PLC 22 August 2016 Amphion Innovations plc ("Amphion" or "the Company") Additional Draw Down on Loan Facility London and New York, 22 August 2016 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that the Company has agreed terms fo...

Holding(s) in Company

RNS Number: 1809G Kromek Group PLC 03 August 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Kromek Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights x An acquisitio...

Results of AGM and Directorate Change

RNS Number: 6005F Amphion Innovations PLC 29 July 2016 Amphion Innovations plc ("Amphion" or "the Company") Results of AGM and Directorate Change London and New York, 29 July 2016 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that all resolutions were passed at the Annual...

Latest discussion posts More

  • Re: Expensive drawdown facility

    What to do? Sell or avoid? Have been watching this, but any upside to Motif will simply mean AMP selling stake to pay the debt/bills? Will any Motif windfall be squandered? ...
    15-Jul-2016
    bobsson
  • Re: Expensive drawdown facility

    Agree wholeheartedly! Conflicted company officers are electing, against their fiduciary duty, to unecessarily bleed our company dry when cheaper funding could clearly be ...
    13-Jul-2016
    nodebt
  • Expensive drawdown facility

    This facility seems very expensive $750,000 borrowed today and $881,000 having to be repaid in less than 4 months time and some of it being used to pay back a previous ...
    13-Jul-2016
    northumbrian-piper

Users' HoldingsMore

Users who hold Amphion Innovations also hold..
MOTIF BIO25%
UK OIL & GAS21%
LLOYDS GRP.17%
LENOVO14%
BP14%

Codes & Symbols

ISINGB00B0DJNP99
SymbolsAMP, LSE:AMP, AMP.L, AMP:LN, LON:AMP, XLON:AMP